Finding medicines that can kill cancer cells while leaving normal tissue unscathed is a Holy Grail of oncology research. In two new papers, scientists at UC San Francisco and Princeton University present complementary strategies to crack this problem with “smart” cell therapies—living medicines that remain ...

A national study evaluating a personalized approach to breast cancer screening and risk assessment has launched a new effort to diversify its participants, as it hits a milestone of 30,000 women enrolled.   The multiyear WISDOM study (Women Informed to Screen Depending on Measures of risk), led ...

  For 40 years, Christine Miaskowksi, RN, PhD, FAAN, has been investigating the causes of- and solutions for the debilitating side effects of cancer treatment. In recognition of her contributions as a nurse scientist, Miaskowski recently received one of nursing’s pre-eminent awards. Below, Miaskowski ...

Mekhail Anwar, MD, PhD, associate professor in residence in the Dept. of Radiation Oncology, recently received an NIH New Innovator Award. His project, titled INSITE (Implantable Photonic Sensors for Immunoresponse in the Tumor microenvironment), proposes to assess response or resistance to immunotherapy by implanting a ...

As we continue to cope with the ongoing coronavirus pandemic nationwide, a second public health crisis is emerging and causing increasing alarm. Stemming from the initial deferrals of routine care as the pandemic took hold, combined with shelter-in-place health orders and the fears generated by ...